富士康成立新公司 加快推進製造新能源車產業項目
對於有內地媒體引述天眼查資料顯示,富士康新能源汽車產業發展(河南)有限公司近日正式成立一事,據《中國證券報》引述富士康方面回應表示,根據集團3+3戰略產業規劃,去年富士康科技集團在鄭州設立富士康新事業總部,並成立富士康新事業發展集團,統籌規劃包括新能源汽車及電池等在內的新產業發展。此次富士康新事業發展集團旗下新設立的富士康新能源汽車產業發展(河南)有限公司,將進一步聚焦新能源汽車產業,加快項目推進實施。
股東信息顯示,富士康新能源汽車產業發展(河南)有限公司由富士康新事業發展集團全資持股,而富士康新事業發展集團為鴻富錦精密電子(鄭州)有限公司全資子公司。(ta/cy) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.